MARKET

INFI

INFI

Infinity Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.110
-0.020
-1.77%
Closed 16:00 10/22 EDT
OPEN
1.140
PREV CLOSE
1.130
HIGH
1.145
LOW
1.100
VOLUME
24.57K
TURNOVER
--
52 WEEK HIGH
2.590
52 WEEK LOW
0.9600
MARKET CAP
63.30M
P/E (TTM)
-3.2801
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of INFI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

INFI News

  • Verastem's (VSTM) Copiktra Gets Orphan Drug Designation
  • Zacks.10/08 15:02
  • Infinity's (INFI) IPI-549 in Focus in a Crowded Cancer Space
  • Zacks.10/08 13:18
  • The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo
  • Benzinga.10/03 11:34
  • Infinity Initiates 2 Studies for Lead Candidate IPI-549
  • Zacks.09/05 15:24

More

Industry

Biotechnology & Medical Research
+0.44%
Pharmaceuticals & Medical Research
+0.60%

Hot Stocks

Name
Price
%Change

About INFI

Infinity Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and delivery of medicines to treat diseases. The Company develops small molecule drugs that target disease pathways for potential applications in oncology. Its product candidate is duvelisib, also known as IPI-145, is an oral, dual-inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K), for the treatment of hematologic malignancies, or blood cancers. The Company is also developing IPI-549, which is an orally administered, clinical-stage, immuno-oncology product candidate that selectively inhibits the gamma isoform of PI3K. In addition to duvelisib, the Company focuses to generate new product candidates for potential investigation in oncology. The Company also focuses on developing DYNAMO, CONTEMPO, BRAVURA, FRESCO, DYNAMO+R, DUO, SYNCHRONY and Duvelisib + Venetoclax.
More

Webull offers Infinity Pharmaceuticals Inc. (INFI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.